1. Home
  2. BELFB vs AVBP Comparison

BELFB vs AVBP Comparison

Compare BELFB & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BELFB
  • AVBP
  • Stock Information
  • Founded
  • BELFB 1949
  • AVBP 2021
  • Country
  • BELFB United States
  • AVBP United States
  • Employees
  • BELFB N/A
  • AVBP N/A
  • Industry
  • BELFB
  • AVBP
  • Sector
  • BELFB
  • AVBP
  • Exchange
  • BELFB Nasdaq
  • AVBP NYSE
  • Market Cap
  • BELFB 865.9M
  • AVBP 705.8M
  • IPO Year
  • BELFB N/A
  • AVBP 2024
  • Fundamental
  • Price
  • BELFB $90.51
  • AVBP $25.22
  • Analyst Decision
  • BELFB Strong Buy
  • AVBP Strong Buy
  • Analyst Count
  • BELFB 4
  • AVBP 7
  • Target Price
  • BELFB $95.75
  • AVBP $39.29
  • AVG Volume (30 Days)
  • BELFB 134.5K
  • AVBP 377.5K
  • Earning Date
  • BELFB 07-23-2025
  • AVBP 08-13-2025
  • Dividend Yield
  • BELFB 0.31%
  • AVBP N/A
  • EPS Growth
  • BELFB N/A
  • AVBP N/A
  • EPS
  • BELFB 3.42
  • AVBP N/A
  • Revenue
  • BELFB $558,940,000.00
  • AVBP N/A
  • Revenue This Year
  • BELFB $18.21
  • AVBP $66.25
  • Revenue Next Year
  • BELFB $7.91
  • AVBP N/A
  • P/E Ratio
  • BELFB $26.34
  • AVBP N/A
  • Revenue Growth
  • BELFB N/A
  • AVBP N/A
  • 52 Week Low
  • BELFB $58.00
  • AVBP $15.47
  • 52 Week High
  • BELFB $92.61
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • BELFB 75.49
  • AVBP 67.19
  • Support Level
  • BELFB $85.18
  • AVBP $22.65
  • Resistance Level
  • BELFB $91.61
  • AVBP $25.80
  • Average True Range (ATR)
  • BELFB 3.30
  • AVBP 1.32
  • MACD
  • BELFB 1.35
  • AVBP 0.18
  • Stochastic Oscillator
  • BELFB 94.70
  • AVBP 87.89

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: